US Federal 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation (Page 14)

US

US Federal 2025-2026 Regular Session

US Federal House Bill HJR15

Introduced
1/9/25  
This joint resolution nullifies the final rule titled Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment, which was submitted by the Department of Energy on October 6, 2023. The rule adopts more stringent energy conservation standards for commercial water heating equipment under the Energy Policy and Conservation Act in order to achieve more energy savings.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB139

Introduced
1/3/25  
Sunshine Protection Act of 2025
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB123

Introduced
1/3/25  
Improving Science in Chemical Assessments Act This bill modifies procedures related to specified chemical assessments performed by the Environmental Protection Agency (EPA). Specifically, chemical hazard identification and dose response assessments must be performed by the appropriate EPA program office (they are currently performed by the Integrated Risk Information System program). Additionally, the bill requires the EPA to establish a steering committee to ensure there is no duplication of effort by relevant program offices in conducting covered assessments.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB161

Introduced
1/3/25  
Refer
1/3/25  
Refer
1/3/25  
New Source Review Permitting Improvement Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB79

Introduced
1/3/25  
Freedom from Mandates Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB19

Introduced
1/3/25  
To prohibit any entity that receives Federal funds from the COVID relief packages from mandating employees receive a COVID-19 vaccine, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB120

Introduced
1/3/25  
No Mandates Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB238

Introduced
1/7/25  
Healthy Technology Act of 2025 This bill establishes that artificial intelligence (AI) or machine learning technology may be eligible to prescribe drugs.Currently, certain drugs may be dispensed only upon a prescription provided by a practitioner licensed by law to administer the drug. Under this bill, an AI or machine learning technology may qualify as such a prescribing practitioner if the technology is (1) authorized by state law to prescribe the drug involved; and (2) approved, cleared, or authorized under certain federal provisions pertaining to medical devices and products.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB380

Introduced
1/14/25  
Affordable Shipping for All Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB381

Introduced
1/14/25  
LNG Public Interest Determination Act of 2025
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB382

Introduced
1/14/25  
Exported Carbon Emissions Report Act of 2025This bill directs the Environmental Protection Agency (EPA) to annually collect, calculate, and publish information on certain emissions of carbon dioxide and methane from fossil fuels. Specifically, the EPA must publish information, for each of the previous 10 years, on the total emissions of carbon dioxide and methane that are released (1) within the boundaries of the United States that are the result of the extraction, processing, transportation, combustion, and other use of fossil fuels; and (2) outside the boundaries of the United States that are the result of leakage and combustion of fossil fuels produced or refined in the United States and subsequently exported.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB391

Introduced
1/14/25  
Extend the TikTok Deadline Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB379

Introduced
1/14/25  
Healthcare Freedom and Choice Act
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB694

Introduced
1/23/25  
Refer
1/23/25  
Restoring Trade Fairness ActThis bill establishes various trade measures related to China, including by revoking China's permanent normal trade relations (PNTR) status and increasing the rates of duty (i.e., tariffs) on Chinese imported goods. The bill prohibits imported goods originating from North Korea, China, Russia, or Iran from receiving de minimis treatment. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, the bill revokes China's PNTR status. Currently, China's PNTR status allows for Chinese goods to have duty rates set forth in column 1 of the Harmonized Tariff Schedule of the United States (HTS). With the removal of China's PNTR status, the bill generally sets the applicable duty rates on imported Chinese goods at the higher rates listed in column 2 of the HTS, with exceptions.The bill establishes a minimum duty rate of 35% for all Chinese goods, which requires column 2 rates to be at least 35%. However, the bill establishes a minimum duty rate of 100% for a list of specified goods (e.g., various minerals, certain vaccines and drugs, and certain defense-related articles). Duty rates are phased in over five years and adjusted annually for inflation.The bill alsoauthorizes the President to take additional actions related to trade with China, requires merchandise imported from China to be appraised based on U.S. value, and establishes a trust fund to compensate U.S. producers for lost revenue resulting from retaliatory actions by China.
US

US Federal 2025-2026 Regular Session

US Federal House Bill HB675

Introduced
1/23/25  
Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2025 or the Domestic SUPPLY Act of 2025This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) to address infectious diseases and other public health emergencies.Specifically, the Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements with eligible domestic manufacturers for PPE to prepare for and respond to public health emergencies. To be eligible, manufacturers must be majority owned and operated by U.S. citizens and must manufacture a majority of their contracted products domestically, with 100% of products manufactured domestically by 2028. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program.In addition, the federal government must only procure, subject to limited exceptions, clothing or equipment that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure such items domestically.Further, the bill requires HHS to submit to Congress a report about changes to federal requirements for PPE since the beginning of the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.